Roger Stein: A bold new way to fund drug research
Roger Stein: Una nueva y audaz forma de financiar la investigación de fármacos.
Roger Stein wants to bring financial engineering to the world of drug funding. Full bio
Double-click the English transcript below to play the video.
that actually touches everybody.
en algún momento de la vida.
about a one in three chance
es un tercio
we think about raising money
forma de recaudar fondos
for Financial Engineering at MIT,
ingeniería financiera en MIT,
his own bits of research,
su propia investigación,
del desarrollo de medicamentos,
something we could do.
how to make a cancer drug.
fármaco contra el cáncer.
of other things gets done.
cáncer y otros asuntos.
the drug to healthy people
fármacos se abandonan en ese momento.
to see if the drug's effective,
ver si la droga es eficaz.
give it to people with cancer
Muchos desisten.
test it on a very large sample,
is what the right dose is, and also,
es la dosis correcta y también
muy pequeño de fármacos
come out the other side.
pasarlo por completo.
esas botellas azules salvan vidas
you have one of the blue ones.
decir si era una de las azules.
them as financial assets?"
en esto como activos financieros?"
structures and all that,
but in order to make it work,
called the Valley of Death
you can't get to the later stages.
se puede avanzar a etapas porteriores.
but now we need a lot of capital,
ahora necesitamos un gran capital
Philanthropies don't have it.
Los filántropos tampoco.
get people in the capital markets,
de los mercados de capitales,
a next phase of approval,
valor, se pueden vender
pagar los intereses de los bonos,
fund the next round of trials.
la próxima ronda de ensayos.
algo más o menos sorprendente.
estructurar ese fondo
about five to eight percent,
about a 12-percent return.
who want to make those big bets
that would be interested in that.
personas interesadas.
in the academic press.
artículos en revistas académicas,
just make people aware of it, though.
apenas darlo a conocer.
took all of our computer code
los códigos de computadora
to see if this would work.
y ver si funciona.
porque la gente
and see how it would work.
suposiciones y ver cómo funcionan.
the world to fund this stuff?
para financiar estas cosas?
more than just money that's required.
dinero no es lo único que se necesita.
people to get involved,
que se involucrare,
the different things that could go wrong.
cosas que pueden salir mal.
this that might get in the way?
partes del problema
a work stream on credit risk?
el proceso con créditos de riesgo?
on the regulatory aspects?
esas normas regulatorias?
the summer, this past summer.
en el verano pasado.
that we thought would be important,
que podrían ser interesantes,
and heard the reports
and they talked about it.
it was the summertime --
estábamos en pleno verano...
tenido gente trabajando
alguien más lo haga.
los planes de pensiones,
financiar cientos de ensayos,
ABOUT THE SPEAKER
Roger Stein - Financial management expertRoger Stein wants to bring financial engineering to the world of drug funding.
Why you should listen
Roger Stein is a senior lecturer in finance at MIT's Sloan School of Management and a research affiliate at the MIT Laboratory for Financial Engineering. He is also the former chief analytics officer at State Street Global Exchange. He has been working in risk modeling and financial prediction for almost 25 years; his products and services are used widely in industry and have become benchmarks in banking and finance. With MIT colleagues, he is currently collaborating on a new model that uses modern risk management methods and financial engineering techniques to change the way new drug research is funded.
Previously he was managing director of research and academic relations globally for Moody’s Corporation, and prior to that was president of Moody’s Research Labs. He has a Ph.D. from New York University, has coauthored two full-length texts on applied analytics, and has written more than 50 academic articles and papers. He has also been practicing Aikido since 1980.
Roger Stein | Speaker | TED.com